Cannabis: high time for evidence-based policies.

The Lancet Oncology

The Lancet Oncology.

Lancet Oncol ; 18(1): 1, 2017 01.

Article in En | MEDLINE | ID: mdl-28049567

Subject(s)

Evidence-Based Medicine/legislation & jurisprudence; Health Policy; Marijuana Abuse; Marijuana Smoking/legislation & jurisprudence; Medical Marijuana/therapeutic use; Cost-Benefit Analysis; Evidence-Based Medicine/economics; Government Regulation; Health Care Costs/legislation & jurisprudence; Health Policy/economics; Humans; Marijuana Abuse/complications; Marijuana Abuse/economics; Marijuana Abuse/prevention & control; Marijuana Smoking/adverse effects; Marijuana Smoking/economics; Marijuana Smoking/prevention & control; Medical Marijuana/adverse effects; Medical Marijuana/economics; Patient Safety/economics; Policy Making; Risk Assessment; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Marijuana Smoking / Marijuana Abuse / Evidence-Based Medicine / Medical Marijuana / Health Policy Type of study: Etiology_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Lancet Oncol Year: 2017 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google